SCHEMBL6970620

SCHEMBL6970620

[CH2]Oc1ccc2[nH]ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.50
NR4A2 P43354 2/20 0.50
LTA4H P09960 2/20 0.50
CYP2A6 P11509 2/20 0.50
F7 P08709 1/20 0.50
F3 P13726 1/20 0.50
USP2 O75604 1/20 0.50
GAA P10253 1/20 0.50
ALOX15 P16050 1/20 0.50
RAD51 Q06609 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MAOA P21397 2/20 0.47
IMPDH2 P12268 1/20 0.46
IMPDH1 P20839 1/20 0.46
MEN1 O00255 1/20 0.46
POLB P06746 1/20 0.46
MAPK1 P28482 1/20 0.46
KMT2A Q03164 1/20 0.46
NPC1 O15118 1/20 0.46
HDAC1 Q13547 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20721531 0.83 MEN1 (0.66) AHRNR4A2LTA4HCYP2A6MAOA
SCHEMBL25462527 0.79 AHR (0.50) AHRNR4A2LTA4HCYP2A6F7
SCHEMBL2426021 0.79 AHR (0.55) AHRNR4A2LTA4HCYP2A6F7
SCHEMBL29992449 0.79 MEN1 (0.71) AHRNR4A2LTA4HCYP2A6F7
SCHEMBL4952881 0.79 AHR (0.55) AHRNR4A2LTA4HCYP2A6F7
SCHEMBL3871546 0.79 AHR (0.55) AHRNR4A2LTA4HCYP2A6F7
SCHEMBL74720 0.79 MEN1 (0.71) AHRNR4A2LTA4HCYP2A6F7
Ammonia Solution, Strong SCHEMBL28589598 0.78 MEN1 (0.69) AHRNR4A2LTA4HCYP2A6F7
SCHEMBL417223 0.78 AHR (0.48) AHRNR4A2LTA4HCYP2A6F7
Hydrochloric Acid SCHEMBL27528155 0.78 MEN1 (0.69) AHRNR4A2LTA4HCYP2A6F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015087094-A1 NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SEMMELWEIS EGYETEM (HU) 2015-06-18 WO claimed
WO-2015087094-A1 NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SEMMELWEIS EGYETEM (HU) 2015-06-18 WO disclosed
US-6642255-B2 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-11-04 US disclosed
EP-1355648-A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) Bristol-Myers Squibb Pharma Company (US) 2003-10-29 EP disclosed
WO-2002055491-A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) BRISTOL MYERS SQUIBB COMPANY P (US) 2002-07-18 WO disclosed